Drug delivery is important not only for ensuring bioavailability for therapeutic benefit but also for product differentiation and market success. DCAT Value Chain Insights highlights technology advances in drug delivery for injectable and solid-dosage drugs and other products from recent start-ups, partnering deals, and mergers and acquisitions. For the text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)

Mergers and acquisitions

Partnering

Start-ups

New strategy/management

Sponsor: Vetter Pharma International GmbH